These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 12519093

  • 1. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
    Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M.
    Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
    [Abstract] [Full Text] [Related]

  • 2. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde OE.
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [Abstract] [Full Text] [Related]

  • 3. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 4. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
    Isaza C, Henao J, Ramirez E, Cuesta F, Cacabelos R.
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
    [Abstract] [Full Text] [Related]

  • 5. Presynaptic alpha-2C adrenoceptor-mediated control of noradrenaline release in humans: genotype- or age-dependent?
    Bruck H, Schwerdtfeger T, Toliat M, Leineweber K, Heusch G, Philipp T, Nürnberg P, Brodde OE.
    Clin Pharmacol Ther; 2007 Nov; 82(5):525-30. PubMed ID: 17410123
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
    Turnes J, Hernández-Guerra M, Abraldes JG, Bellot P, Oliva R, García-Pagán JC, Bosch J.
    Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
    [Abstract] [Full Text] [Related]

  • 8. Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea.
    Börgel J, Schulz T, Bartels NK, Epplen JT, Büchner N, Rump LC, Huesing A, Sanner BM, Mügge A.
    Clin Sci (Lond); 2006 Jan; 110(1):117-23. PubMed ID: 16122377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Circulation; 2005 Jun 28; 111(25):3429-34. PubMed ID: 15956122
    [Abstract] [Full Text] [Related]

  • 11. Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.
    Maman SR, Vargas AF, Ahmad TA, Miller AJ, Gao Z, Leuenberger UA, Proctor DN, Muller MD.
    J Appl Physiol (1985); 2017 Aug 01; 123(2):337-343. PubMed ID: 28572492
    [Abstract] [Full Text] [Related]

  • 12. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
    Larsson PT, Wallén NH, Martinsson A, Egberg N, Hjemdahl P.
    Thromb Haemost; 1992 Dec 07; 68(6):687-93. PubMed ID: 1337630
    [Abstract] [Full Text] [Related]

  • 13. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
    Bruck H, Leineweber K, Beilfuss A, Weber M, Heusch G, Philipp T, Brodde OE.
    Clin Pharmacol Ther; 2003 Sep 07; 74(3):255-63. PubMed ID: 12966369
    [Abstract] [Full Text] [Related]

  • 14. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
    Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T, Brodde OE.
    Clin Pharmacol Ther; 2005 Sep 07; 78(3):232-8. PubMed ID: 16153394
    [Abstract] [Full Text] [Related]

  • 15. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
    Brodde OE.
    Fundam Clin Pharmacol; 2008 Apr 07; 22(2):107-25. PubMed ID: 18353108
    [Abstract] [Full Text] [Related]

  • 16. Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.
    Vargas-Alarcón G, Fragoso JM, Cruz-Robles D, Vargas A, Martinez A, Lao-Villadóniga JI, García-Fructuoso F, Vallejo M, Martínez-Lavín M.
    Arthritis Rheum; 2009 Jul 07; 60(7):2169-73. PubMed ID: 19565482
    [Abstract] [Full Text] [Related]

  • 17. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH.
    Clin Pharmacol Ther; 2003 Oct 07; 74(4):372-9. PubMed ID: 14534524
    [Abstract] [Full Text] [Related]

  • 18. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF, Hill JA, Aranda JM, Johnson JA.
    Pharmacogenet Genomics; 2007 Apr 07; 17(4):277-82. PubMed ID: 17496726
    [Abstract] [Full Text] [Related]

  • 19. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
    Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML.
    Am J Hypertens; 2005 Nov 07; 18(11):1508-16. PubMed ID: 16280290
    [Abstract] [Full Text] [Related]

  • 20. Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype.
    King D, Etzel JP, Chopra S, Smith J, Cadman PE, Rao F, Funk SD, Rana BK, Schork NJ, Insel PA, O'Connor DT.
    Clin Pharmacol Ther; 2005 May 07; 77(5):388-403. PubMed ID: 15900285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.